Back to TARS

Frazier Life Sciences Management, L.P. → TARS

Frazier Life Sciences Management, L.P. TARS Position History

Tarsus Pharmaceuticals, Inc. • Healthcare

Quarters held
4
Latest value
$56.6M
Q3 2026
Peak value
$59.7M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$59.7M
Q1 2026$51.1M
Q2 2026$45.9M
Q3 2026$56.6M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$56.6M720.3K——
Q2 2026$45.9M728.6K——
Q1 2026$51.1M728.6K——
Q4 2025$59.7M728.6K——

Other funds holding TARS

Other Frazier Life Sciences Management, L.P. positions

MIRM

MIRUM PHARMACEUTICALS INC

$899.1M
MIRM

MIRUM PHARMACEUTICALS INC

$709.4M
MIRM

MIRUM PHARMACEUTICALS INC

$656.5M
NAMSW

NEWAMSTERDAM PHARMA COMPANY

$613M
NAMSW

NEWAMSTERDAM PHARMA COMPANY

$594.4M
NAMSW

NEWAMSTERDAM PHARMA COMPANY

$542.4M
MIRM

MIRUM PHARMACEUTICALS INC

$536.7M
NAMSW

NEWAMSTERDAM PHARMA COMPANY

$461.8M